Desq Long
Sign in

Company

Vera Therapeutics, Inc.

VERA · CIK 0001831828

SEC FORM 4
$53,590.80

Vera Therapeutics, Inc. (VERA)

Acquisition (code M) of 18,500 shares at $2.8968 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001859453-26-000015 · filed 2026-09-17 · View filing →

SEC FORM 4
$684,500.00

Vera Therapeutics, Inc. (VERA)

Sale of 18,500 shares at $37 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001859453-26-000015 · filed 2026-09-17 · View filing →

SEC FORM 4
$19,698.00

Vera Therapeutics, Inc. (VERA)

Acquisition (code M) of 5,000 shares at $3.9396 per share.

Reporting Person Young Joseph R · Officer Title SVP, FINANCE, CHIEF ACCT OFFCR · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001861684-26-000006 · filed 2026-09-14 · View filing →

SEC FORM 4
$53,590.80

Vera Therapeutics, Inc. (VERA)

Acquisition (code M) of 18,500 shares at $2.8968 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001859453-26-000014 · filed 2026-09-04 · View filing →

SEC FORM 4
$649,642.30

Vera Therapeutics, Inc. (VERA)

Sale of 18,500 shares at $35.1158 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001859453-26-000014 · filed 2026-09-04 · View filing →

SEC FORM 4
$133,977.00

Vera Therapeutics, Inc. (VERA)

Acquisition (code M) of 46,250 shares at $2.8968 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Jul 7, 2026 · Disclosed Aug 12, 2026FILED +36 DAYS

Source: SEC Form 4 · 0001859453-26-000013 · filed 2026-08-12 · View filing →

SEC FORM 4
$40,776.20

Vera Therapeutics, Inc. (VERA)

Sale of 1,000 shares at $40.7762 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Jul 7, 2026 · Disclosed Aug 12, 2026FILED +36 DAYS

Source: SEC Form 4 · 0001859453-26-000013 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,369,495.68

Vera Therapeutics, Inc. (VERA)

Sale of 32,550 shares at $42.0736 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Jul 7, 2026 · Disclosed Aug 12, 2026FILED +36 DAYS

Source: SEC Form 4 · 0001859453-26-000013 · filed 2026-08-12 · View filing →

SEC FORM 4
$450,006.90

Vera Therapeutics, Inc. (VERA)

Sale of 10,500 shares at $42.8578 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Jul 7, 2026 · Disclosed Aug 12, 2026FILED +36 DAYS

Source: SEC Form 4 · 0001859453-26-000013 · filed 2026-08-12 · View filing →

SEC FORM 4
$95,908.34

Vera Therapeutics, Inc. (VERA)

Sale of 2,200 shares at $43.5947 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Jul 7, 2026 · Disclosed Aug 12, 2026FILED +36 DAYS

Source: SEC Form 4 · 0001859453-26-000013 · filed 2026-08-12 · View filing →

SEC FORM 4
$53,590.80

Vera Therapeutics, Inc. (VERA)

Acquisition (code M) of 18,500 shares at $2.8968 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Jun 23, 2026 · Disclosed Aug 12, 2026FILED +50 DAYS

Source: SEC Form 4 · 0001859453-26-000012 · filed 2026-08-12 · View filing →

SEC FORM 4
$698,387.41

Vera Therapeutics, Inc. (VERA)

Sale of 18,412 shares at $37.9311 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Jun 23, 2026 · Disclosed Aug 12, 2026FILED +50 DAYS

Source: SEC Form 4 · 0001859453-26-000012 · filed 2026-08-12 · View filing →

SEC FORM 4
$3,381.84

Vera Therapeutics, Inc. (VERA)

Sale of 88 shares at $38.43 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded Jun 23, 2026 · Disclosed Aug 12, 2026FILED +50 DAYS

Source: SEC Form 4 · 0001859453-26-000012 · filed 2026-08-12 · View filing →

SEC FORM 4
$53,590.80

Vera Therapeutics, Inc. (VERA)

Acquisition (code M) of 18,500 shares at $2.8968 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded May 12, 2026 · Disclosed Aug 12, 2026FILED +92 DAYS

Source: SEC Form 4 · 0001859453-26-000011 · filed 2026-08-12 · View filing →

SEC FORM 4
$520,978.47

Vera Therapeutics, Inc. (VERA)

Sale of 14,219 shares at $36.6396 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded May 12, 2026 · Disclosed Aug 12, 2026FILED +92 DAYS

Source: SEC Form 4 · 0001859453-26-000011 · filed 2026-08-12 · View filing →

SEC FORM 4
$158,768.59

Vera Therapeutics, Inc. (VERA)

Sale of 4,281 shares at $37.0868 per share.

Reporting Person Fordyce Marshall · Officer Title PRESIDENT AND CEO · Transaction Code S

Traded May 12, 2026 · Disclosed Aug 12, 2026FILED +92 DAYS

Source: SEC Form 4 · 0001859453-26-000011 · filed 2026-08-12 · View filing →